Attention Deficit Hyperactivity Disorder, Sleep Onset Insomnia
Conditions
Brief summary
The study hypothesis is that some children with Attention-Deficit-Hyperactivity-Disorder (ADHD) who also have sleep onset difficulties will improve with Melatonin treatment to an extent similar to that of stimulants treatment. In order to check this hypothesis children with a new ADHD diagnosis who also have sleep difficulties will be treated with either Melatonin or with stimulants (Methylphenidate) for one month. The main outcome will be improvement of the ADHD symptoms.
Interventions
3 mg for body weight \<40kg, 6 mg for body weight \>40kg, once a day 30-60 minutes before sleep
Drug formulary and dose will be decided by the treating neurologist from the available options in Israel (as would be given if not participating in the trial)
Sponsors
Study design
Eligibility
Inclusion criteria
* children 6-18 years old with a new ADHD diagnosis who are candidates for treatment with stimulants * Also they suffer from sleep onset insomnia or difficult awakening
Exclusion criteria
* Drug treatment for ADHD or for sleep problems in the last 6 months * Any other chronic medical treatment * Sleep disorder requiring a different treatment * Asthma in the last 2 years
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ADHD symptoms improvement | a month | ADHD symptoms improvement - a clinical judgement based on history from the patient and parents, and from the teacher report |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Sleep difficulties improvement | 1 month | Sleep difficulties improvement - clinical judgement based on history from the patient and parents and from a sleep diary. |
Countries
Israel